NCT06602869 Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
| NCT ID | NCT06602869 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Montpellier |
| Condition | Non-Tuberculous Mycobacterial Pneumonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 76 participants |
| Start Date | 2024-09-17 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 76 participants in total. It began in 2024-09-17 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.
Eligibility Criteria
Inclusion Criteria: * Patient ≥18 years * Patient previously included in the CIMeNT study * Patient with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype * Patient affiliated to the social security system * Patient registered in the French Cystic Fibrosis Registry * Adult patient capable of spontaneous expectoration or after induction Exclusion Criteria: * Lung transplant patients * Person placed under judicial protection * Pregnant and breastfeeding women
Contact & Investigator
Raphael CHIRON, MD
PRINCIPAL INVESTIGATOR
Hôpital Arnaud de Villeneuve
Frequently Asked Questions
Who can join the NCT06602869 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-Tuberculous Mycobacterial Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06602869 currently recruiting?
Yes, NCT06602869 is actively recruiting participants. Contact the research team at r-chiron@chu-montpellier.fr for enrollment information.
Where is the NCT06602869 trial being conducted?
This trial is being conducted at Montpellier, France.
Who is sponsoring the NCT06602869 clinical trial?
NCT06602869 is sponsored by University Hospital, Montpellier. The principal investigator is Raphael CHIRON, MD at Hôpital Arnaud de Villeneuve. The trial plans to enroll 76 participants.